{"cache_age":86400,"height":280,"html":"<iframe src=\"https://invisiblenetwork.ai/embed/podcast/1179036261/d5ce6bd6132d\" title=\"Dexmedetomidine for hyperactive delirium at the end of life: An open-label single arm pilot study with dose escalation in adult patients admitted to an inpatient palliative care unit, on Invisible Network\" width=\"640\" height=\"280\" style=\"border:0;max-width:100%\" allow=\"fullscreen; picture-in-picture\" allowfullscreen loading=\"lazy\" referrerpolicy=\"no-referrer\"></iframe>","provider_name":"Invisible Network","provider_url":"https://invisiblenetwork.ai/","title":"Dexmedetomidine for hyperactive delirium at the end of life: An open-label single arm pilot study with dose escalation in adult patients admitted to an inpatient palliative care unit","type":"rich","version":"1.0","width":640}